Literature DB >> 19064751

Comparison of clinical manifestations in Alzheimer disease and dementia with Lewy bodies.

Angela Nervi1, Christiane Reitz, Ming-Xin Tang, Vincent Santana, Angel Piriz, Dolly Reyes-Dumeyer, Rafael Lantigua, Martin Medrano, Ivonne Z Jiménez-Velázquez, Joseph H Lee, Richard Mayeux.   

Abstract

BACKGROUND: The clinical delineation of dementia with Lewy bodies (DLB) from Alzheimer disease (AD) remains unclear.
OBJECTIVES: To compare neuropsychological profiles in DLB and AD among Caribbean Hispanic family members and participants in a population-based epidemiologic sample using extended neuropsychological test batteries and to explore whether these differences were related to heritable factors.
DESIGN: Cross-sectional study.
SETTING: Clinics in northern Manhattan (New York City), the Dominican Republic, and Puerto Rico. PATIENTS: We compared measures of memory, orientation, language, and executive and visuospatial functioning between patients with DLB vs AD in 2 Caribbean Hispanic cohorts, including a family sample (89 patients with DLB and 118 patients with AD) and an epidemiologic sample (70 patients with DLB and 157 patients with AD). Patients with DLB in the family sample were further categorized as patients having at least 2 family members with DLB or as patients having 1 family member with DLB. MAIN OUTCOME MEASURES: To determine whether observed differences in cognitive profiles were driven by heritable factors, we repeated analyses in the epidemiologic sample after excluding familial cases. We applied general linear models adjusted for age, sex, educational level, disease duration, and apolipoprotein E epsilon4 (OMIM 104310) genotype.
RESULTS: Patients with DLB in both samples were more severely impaired in orientation, visuoconstruction, and nonverbal reasoning after controlling for potential confounders. Patients having at least 2 family members with DLB had the most severe impairment in memory, followed by patients having 1 family member with DLB, and then by patients with AD. After excluding familial AD and DLB cases in the epidemiologic sample, the differences between the groups persisted but were attenuated.
CONCLUSIONS: Compared with patients having AD, patients having DLB are more severely impaired in various cognitive domains, particularly orientation and visuospatial functioning. The difference seems stronger in familial DLB than in sporadic DLB. Whether this divergence in cognitive functions is caused by gene-gene or gene-environmental interactions remains unclear.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064751      PMCID: PMC2633487          DOI: 10.1001/archneur.65.12.1634

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  58 in total

Review 1.  Is dementia with Lewy bodies the second most common cause of dementia?

Authors:  Judith L Heidebrink
Journal:  J Geriatr Psychiatry Neurol       Date:  2002       Impact factor: 2.680

2.  Lewy bodies in cerebral cortex, report of three cases.

Authors:  K Kosaka
Journal:  Acta Neuropathol       Date:  1978-05-24       Impact factor: 17.088

3.  Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.

Authors:  R H Perry; D Irving; G Blessed; A Fairbairn; E K Perry
Journal:  J Neurol Sci       Date:  1990-02       Impact factor: 3.181

4.  The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Authors:  L Hansen; D Salmon; D Galasko; E Masliah; R Katzman; R DeTeresa; L Thal; M M Pay; R Hofstetter; M Klauber
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

5.  Diffuse Lewy body disease: clinical features in 15 cases.

Authors:  E J Byrne; G Lennox; J Lowe; R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 6.  Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia.

Authors:  Daniel Collerton; David Burn; Ian McKeith; John O'Brien
Journal:  Dement Geriatr Cogn Disord       Date:  2003       Impact factor: 2.959

7.  Differential memory impairment in dementia with Lewy bodies and Alzheimer's disease.

Authors:  M Simard; R van Reekum; D Myran; M Panisset; T Cohen; M Freedman; S Black; B Suvajac
Journal:  Brain Cogn       Date:  2002-07       Impact factor: 2.310

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease.

Authors:  Michael Serby; Adam M Brickman; Vahram Haroutunian; Dushyant P Purohit; Deborah Marin; Melinda Lantz; Richard C Mohs; Kenneth L Davis
Journal:  Am J Geriatr Psychiatry       Date:  2003 May-Jun       Impact factor: 4.105

10.  Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

Authors:  Enrique Noe; Karen Marder; Karen L Bell; Diane M Jacobs; Jennifer J Manly; Yaakov Stern
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

View more
  7 in total

1.  Dementia with lewy bodies: diagnosis and management for primary care providers.

Authors:  Melanie Zupancic; Aman Mahajan; Kamna Handa
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Risk of decline in functional activities in dementia with Lewy bodies and Alzheimer disease.

Authors:  Dawn P Gill; Thomas D Koepsell; Rebecca A Hubbard; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

Review 3.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

4.  Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies.

Authors:  P T Nelson; R J Kryscio; G A Jicha; E L Abner; F A Schmitt; L O Xu; G Cooper; C D Smith; W R Markesbery
Journal:  Neurology       Date:  2009-10-06       Impact factor: 9.910

5.  Posterior reversible encephalopathy syndrome in a patient with Richter's syndrome on combination DA-R-EPOCH chemotherapy regimen: a case report.

Authors:  Goar Egoryan; Ricardo Murguia-Fuentes; Mohamed Agab; Nagwa Abou-Ghanem; Maria Adriana Yanez-Bello; Bimatshu Pyakuryal; Daniela Patricia Trelles-Garcia; Rami Ibrahim; Dorota Filipiuk; Adi Gidron; Guillermo Rodriguez-Nava
Journal:  J Med Case Rep       Date:  2021-04-12

Review 6.  Using structural and diffusion magnetic resonance imaging to differentiate the dementias.

Authors:  Sana Suri; Anya Topiwala; Clare E Mackay; Klaus P Ebmeier; Nicola Filippini
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

Review 7.  The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer's Disease-related Pathogenesis.

Authors:  Seong Gak Jeon; Anji Yoo; Dong Wook Chun; Sang Bum Hong; Hyunju Chung; Jin-Il Kim; Minho Moon
Journal:  Aging Dis       Date:  2020-05-09       Impact factor: 6.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.